InCode BioParmaceutics, Inc. Company Profile

06:04 EDT 25th September 2017 | BioPortfolio

News Articles [1 Associated News Articles listed on BioPortfolio]

Ferrer inCode SL Product Pipeline Analysis, 2017 Update [Updated: 27042017] Prices from USD $750

SummaryFerrer inCode SL Ferrer, a subsidiary of Grupo Ferrer Internacional SA is a provider of molecular diagnostics and personalized medicine solutions. The company offers biotechnological solutions ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

InCode BioParmaceutics, Inc.

InCode BioPharmaceutics, Inc.

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for ...

More Information about "InCode BioParmaceutics, Inc." on BioPortfolio

We have published hundreds of InCode BioParmaceutics, Inc. news stories on BioPortfolio along with dozens of InCode BioParmaceutics, Inc. Clinical Trials and PubMed Articles about InCode BioParmaceutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InCode BioParmaceutics, Inc. Companies in our database. You can also find out about relevant InCode BioParmaceutics, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record